Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.55
Bid: 129.05
Ask: 129.10
Change: 1.55 (1.22%)
Spread: 0.05 (0.039%)
Open: 127.90
High: 131.00
Low: 126.90
Prev. Close: 127.00
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

9 Mar 2022 12:15

RNS Number : 2116E
Centrica PLC
09 March 2022
 

9 March 2022

Centrica plc

('Centrica' or 'the Company')

Centrica appoints Non-Executive Director

Centrica plc is pleased to announce the appointment of Nathan Bostock as a Non-Executive Director of the Company, with effect from 9 May 2022. Nathan will become a member of the Audit & Risk Committee and Nominations Committee.

Scott Wheway, Chairman, said: "I look forward to welcoming Nathan to the Board in May as a Non-Executive Director. Nathan brings a wealth of expertise in financial risk management at the highest level and significant commercial experience, particularly in large scale customer-facing businesses, that will be of great benefit to the Board."

Centrica also announces that Amber Rudd, Non-Executive Director, has been appointed a member of the Nominations Committee with effect from today.

Notes

1. This announcement is made pursuant to Listing Rule 9.6.11R.

2. In accordance with obligations under Listing Rule 9.6.13R, Nathan Bostock holds or has held the following directorships of a publicly quoted company in the previous five years:

 

· Santander UK Group Holdings plc

· Santander UK plc

 

3. There is no further information to be disclosed in relation to Nathan Bostock pursuant to Listing Rules 9.6.13R (1) to 9.6.13R (6) inclusive.

4. At the date of this announcement, Nathan Bostock has no beneficial interest in ordinary shares of Centrica plc.

ENDS

Enquiries:

Investors and AnalystsT: 01753 494900E: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

Notes to Editors:

Nathan Bostock is Chief Executive Officer of Santander UK plc (Santander UK), having been appointed to the role in 2014. Nathan joined Santander UK from The Royal Bank of Scotland plc (RBS), where he was an Executive Director and Group Finance Director. He previously held the post of Group Chief Risk Officer, having joined RBS in 2009. Nathan served on the Board of Abbey National plc (now Santander UK) as an Executive Director, from 2005 until 2009. He joined Abbey National plc in 2001, holding a number of senior positions including Chief Financial Officer and Executive Director of Finance, Markets and Human Resources.

Mr Bostock is a chartered accountant and holds a BSc (Hons) in Mathematics. 

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJLMTTMTMMBPT
Date   Source Headline
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:20 pmRNSAnnual Financial Report 2023
25th Mar 20246:00 pmRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20246:00 pmRNSTransaction in Own Shares
21st Mar 20246:00 pmRNSTransaction in Own Shares
20th Mar 20246:00 pmRNSTransaction in Own Shares
19th Mar 20246:00 pmRNSTransaction in Own Shares
18th Mar 20246:00 pmRNSTransaction in Own Shares
15th Mar 20246:26 pmRNSTransaction in Own Shares
14th Mar 20246:00 pmRNSTransaction in Own Shares
13th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20245:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.